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Exosomes are extracellular vesicles with nano size range. The use of exosomes as 
drug delivery vehicle has useful advantages compared to other vesicular systems. 
Exosomes are nonimmunogenic, nontoxic, and stable with good composition and 
potency for crossing blood brain barrier. They can be used as theranostic agents and 
vaccine therapy. The exosomes are a new choice for nonimmunogenic targeted drug 
delivery vehicle. 
Introduction: Exosomes are nano size vesicles secreted by different cell types. The 
main role of exosomes in the body is a cell to cell communication. They are not 
immunogenic due to similar structure as body cells. They can cross blood brain 
barrier, stable in the blood circulation, biocompatible, with low toxicity, suitable 
size, and structure. These endogenous vesicles can be used for drug delivery, 
immunevaccines and as diagnostic agents. 
Methods: The following databases were reviewed for bibliography of using 
exosomes as delivery agents: Web of science, Scopus, Medline, and Embase. 
Results: Exosomes can deliver different kinds of cargos (RNA, proteins and small 
molecules) to the target cells. Exosome as a biomarker of diseases (cancer, 
cardiovascular disease, MS, etc) personalized therapy with the exosomes that 
generated from induced pluripotent stem cell (iPSC) derived that used for patient 
specific and disease specific cell therapy. They have specific role in tissue repair and 
regeneration, vaccines for immunotherapy (phase II of clinical trial). The strategies 
to introduce drugs into exosomes are active and passive loading. Artificial exosome 
mimetics can be isolated from exosome secreting cell lines but these exosomes in 
comparison with autologous are immunogenic. Isolation techniques of exosomes are 
ultracentrifugation, electron microscopy, and SDS page. Exosomes were mainly 
taken up by macrophages in the liver after IV administration. Exosomes 
characterization methods are biophysical, molecular and microfluidics. 
Conclusion: Exosomes are good carriers for delivery of drugs and genes to the 
target without immunogenic reaction. They can be used as immunovacines for the 
cancer treatment by activating immune system against tumor cells. Exosomes can 
substitution the liposomes because of their size, structure, non-immunogenicity and 
their natural composition. 
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